March 9, 2020 / 6:43 AM / 20 days ago

BRIEF-Nicox Announces Additional Approval For Vyzulta In Taiwan

March 9 (Reuters) - NICOX SA:

* NICOX SA TODAY ANNOUNCES THAT ITS PARTNER, BAUSCH + LOMB, HAS RECEIVED APPROVAL FOR VYZULTA (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION), 0.024% IN TAIWAN. Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below